A novel peptide stapling reaction using 2,6-dicyanopyridine works in water at physiological pH, enabling direct screening of constrained peptides that showed 28-fold stronger Zika protease inhibition.
28-fold stronger inhibitionStapled peptide vs. linear analogue against Zika NS2B-NS3 protease
What the researchers found
A biocompatible two-component stapling reaction enables in-situ generation of constrained peptides in aqueous solution, with a stapled Zika protease inhibitor showing 28-fold improved potency over its linear analogue.
Why it matters
Constrained peptides are more drug-like but hard to make and screen. A biocompatible stapling method that works in biochemical conditions dramatically accelerates drug discovery for peptide therapeutics.
The numbers in context
>28-fold improved inhibition; aqueous pH 7 reaction; on-resin or post-purification stapling; orthogonal to natural amino acids
How the study worked
In-vitro chemistry development and screening study testing a new stapling reaction on solid-phase and in solution, validated by screening constrained peptides against Zika NS2B-NS3 protease.
Who was studied
Short peptide library targeting Zika virus NS2B-NS3 protease; linear vs stapled comparison
What this study cannot tell us
In-vitro proof of concept only; Zika protease is one target — breadth of applicability needs demonstration; in-vivo pharmacokinetics of stapled products not tested.
How to read the evidence
Strong proof-of-concept for the chemistry with clear potency improvement, but limited to one target and in-vitro conditions.
When this study was published
Published in 2020; peptide stapling and constrained peptide drug design continue to advance rapidly.
The bigger picture
This represents a methodological breakthrough — enabling peptide drug discovery to screen constrained forms directly, rather than testing linear peptides and hoping the constrained version works similarly.
Questions still open
- Can this stapling chemistry be applied to larger peptide libraries for high-throughput screening?
- How do the stapled peptides perform in vivo — stability, bioavailability, and toxicity?
- Could this approach generate constrained peptide therapeutics for other viral proteases?
Common questions
What is peptide stapling?
Why is biocompatible stapling important?
Read the original research
A biocompatible stapling reaction for in situ generation of constrained peptides.
Chemical science, 12(2), 669-674
Citation
Morewood, Richard; Nitsche, Christoph. (2020). A biocompatible stapling reaction for in situ generation of constrained peptides.. Chemical science, 12(2), 669-674. https://doi.org/10.1039/d0sc05125j